Computational and Network Pharmacology Studies of to Tackle SARS-CoV-2

Overview

Journal Phytomed Plus

Date 2022 Apr 11

PMID 35399824

Authors

Rupesh V Chikhale

Saurabh K Sinha

Pukar Khanal

Nilambari S Gurav

Muniappan Ayyanar

Satyendra K Prasad

Manish M Wanjari

Rajesh B Patil

Shailendra S Gurav

Affiliations

Soon will be listed here.

Abstract

Background: Since December 2019, SARS-CoV-2 had been a significant threat globally, which has accounted for about two million deaths. Several types of research are undergoing and have reported the significant role of repurposing existing drugs and natural lead in the treatment of COVID-19. The plant (Synonym-) (Euphorbiaceae) is a rich source of vitamin C, and its use as an antiviral agent has been well established.

Purpose: The present study was undertaken to investigate the potency of the several components of against three protein targets of 2019-nCoV viz. NSP15 endoribonuclease, main protease, and receptor binding domain of prefusion spike protein using molecular docking and dynamics studies.

Methods: The docking simulation studies were carried out using Schrödinger maestro 2018-1 MM share version, while dynamics studies were conducted to understand the binding mechanism and the complexes' stability studies.

Results: Out of sixty-six tested compounds, Chlorogenic acid, Quercitrin, and Myricetin were most effective in showing the highest binding energy against selected protein targets of SARS-CoV-2. The network pharmacology analysis study confirmed these compounds' role in modulating the immune response, inflammatory cascade, and cytokine storm through different signaling pathways.

Conclusion: Current pharmacoinformatic approach shows possible role of in the treatment and management of COVID-19.

Citing Articles

Remedying SARS-CoV-2 through nature: a review highlighting the potentiality of herbs, trees, mushrooms, and endophytic microorganisms in controlling Coronavirus.

Patni B, Bhattacharyya M, Pokhriyal A, Pandey D Planta. 2025; 261(4):89.

PMID: 40089556 DOI: 10.1007/s00425-025-04647-8.

The efficacy of herbal medicines on the length of stay and negative conversion time/rate outcomes in patients with COVID-19: a systematic review.

Latarissa I, Meiliana A, Sormin I, Sugiono E, Wathoni N, Barliana M Front Pharmacol. 2024; 15:1383359.

PMID: 38873430 PMC: 11169809. DOI: 10.3389/fphar.2024.1383359.

Quest for Anti-SARS-CoV-2 antiviral therapeutics: in-silico and in-vitro analysis of edible mushroom- Cordyceps militaris.

Gandhale P, Chikhale R, Khanal P, Biswa V, Ali R, Khan M J Ayurveda Integr Med. 2024; 15(3):100979.

PMID: 38871595 PMC: 11282376. DOI: 10.1016/j.jaim.2024.100979.

Mechanisms of action of Zishen Yutai pills in treating premature ovarian failure determined by integrating UHPLC-Q-TOF-MS and network pharmacology analysis.

Dang L, Zhang C, Su B, Ning N, Huang Q, Zhou S BMC Complement Med Ther. 2022; 22(1):281.

PMID: 36289509 PMC: 9597968. DOI: 10.1186/s12906-022-03763-2.

Aqueous Extract of L. Alleviates Functional Dyspepsia through Regulating Gastrointestinal Hormones and Gut Microbiome In Vivo.

Li X, Lin Y, Jiang Y, Wu B, Yu Y Foods. 2022; 11(10).

PMID: 35627061 PMC: 9141879. DOI: 10.3390/foods11101491.

References

Palazon A, Goldrath A, Nizet V, Johnson R . HIF transcription factors, inflammation, and immunity. Immunity. 2014; 41(4):518-28. PMC: 4346319. DOI: 10.1016/j.immuni.2014.09.008. View

Johnson D, Chen Y . Ras family of small GTPases in immunity and inflammation. Curr Opin Pharmacol. 2012; 12(4):458-63. PMC: 3374043. DOI: 10.1016/j.coph.2012.02.003. View

Harris M, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R . The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 2003; 32(Database issue):D258-61. PMC: 308770. DOI: 10.1093/nar/gkh036. View

Meselhy M, Kusumoto I, Kadota S, Hattori M, Namba T . Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem Pharm Bull (Tokyo). 1995; 43(4):641-8. DOI: 10.1248/cpb.43.641. View

Khanal P, Chikhale R, Dey Y, Pasha I, Chand S, Gurav N . Withanolides from as an immunity booster and their therapeutic options against COVID-19. J Biomol Struct Dyn. 2021; 40(12):5295-5308. DOI: 10.1080/07391102.2020.1869588. View

Xiang Y, Pei Y, Qu C, Lai Z, Ren Z, Yang K . In vitro anti-herpes simplex virus activity of 1,2,4,6-tetra-O-galloyl-β-D-glucose from Phyllanthus emblica L. (Euphorbiaceae). Phytother Res. 2011; 25(7):975-82. DOI: 10.1002/ptr.3368. View

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

Park J, Lee S, Kim S, Shin S, Lee J, Shin C . Chromone and chromanone derivatives as strand transfer inhibitors of HIV-1 integrase. Arch Pharm Res. 2008; 31(1):1-5. DOI: 10.1007/s12272-008-1111-z. View

Munoz-Fontela C, Mandinova A, Aaronson S, Lee S . Emerging roles of p53 and other tumour-suppressor genes in immune regulation. Nat Rev Immunol. 2016; 16(12):741-750. PMC: 5325695. DOI: 10.1038/nri.2016.99. View

10.

Patil R, Chikhale R, Khanal P, Gurav N, Ayyanar M, Sinha S . Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19. Inform Med Unlocked. 2020; 22:100504. PMC: 7756171. DOI: 10.1016/j.imu.2020.100504. View

11.

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S . SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181(2):271-280.e8. PMC: 7102627. DOI: 10.1016/j.cell.2020.02.052. View

12.

Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S . Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020; 581(7807):215-220. DOI: 10.1038/s41586-020-2180-5. View

13.

Kim Y, Jedrzejczak R, Maltseva N, Wilamowski M, Endres M, Godzik A . Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2. Protein Sci. 2020; 29(7):1596-1605. PMC: 7264519. DOI: 10.1002/pro.3873. View

14.

Li X, Xiang Y, Li F, Yin C, Li B, Ke X . WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment. Front Immunol. 2019; 10:2293. PMC: 6775198. DOI: 10.3389/fimmu.2019.02293. View

15.

De Clercq E . Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med Res Rev. 2000; 20(5):323-49. DOI: 10.1002/1098-1128(200009)20:5<323::aid-med1>3.0.co;2-a. View

16.

Chikhale R, Sinha S, Wanjari M, Gurav N, Ayyanar M, Prasad S . Computational assessment of saikosaponins as adjuvant treatment for COVID-19: molecular docking, dynamics, and network pharmacology analysis. Mol Divers. 2021; 25(3):1889-1904. PMC: 7829483. DOI: 10.1007/s11030-021-10183-w. View

17.

Chikhale R, Gurav S, Patil R, Sinha S, Prasad S, Shakya A . Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an approach. J Biomol Struct Dyn. 2020; 39(12):4510-4521. PMC: 7332873. DOI: 10.1080/07391102.2020.1778539. View

18.

Zenobia C, Hajishengallis G . Basic biology and role of interleukin-17 in immunity and inflammation. Periodontol 2000. 2015; 69(1):142-59. PMC: 4530463. DOI: 10.1111/prd.12083. View

19.

Chikhale R, Sinha S, Patil R, Prasad S, Shakya A, Gurav N . investigation of phytochemicals from as plausible antiviral agent in COVID-19. J Biomol Struct Dyn. 2020; 39(14):5033-5047. PMC: 7335809. DOI: 10.1080/07391102.2020.1784289. View

20.

Li S, Chen C, Zhang H, Guo H, Wang H, Wang L . Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005; 67(1):18-23. PMC: 7114104. DOI: 10.1016/j.antiviral.2005.02.007. View